Maud Charpentier

Also affiliated with Weill Cornell Medicine

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control”.

Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control

Journal of Clinical Investigation(2021)10.1172/jci138740

N/A

0.819DataRank · unranked

234 citations

Nils-Petter Rudqvist, Takahiro Yamazaki, Tuo Zhang, Maud Charpentier, Lorenzo Galluzzi +7 more

Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors

Nature Communications(2023)10.1038/s41467-023-40844-3

N/A

0.624DataRank · unranked

63 citations

Maud Charpentier, Claire Lhuillier, Erik Wennerberg, Sheila Spada, Caroline Sheridan +7 more

Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses

Cancer Immunology Research(2020)10.1158/2326-6066.cir-19-0338

N/A

0DataRank · unranked

47 citations

Maud Charpentier, Elena García-Martínez, Camille Daviaud, Jeffrey Kraynak, Joseph Aryankalayil +3 more

IL15 synergizes with radiotherapy to reprogram the tumor immune contexture through a dendritic cell connection

OncoImmunology(2020)10.1080/2162402x.2020.1790716

N/A

0DataRank · unranked

8 citations

Maud Charpentier, Elena García-Martínez, Sandra Demaria, Karsten A. Pilones

CD40 agonism improves anti-tumor T cell priming induced by the combination of radiation therapy plus CTLA4 inhibition and enhances tumor response

OncoImmunology(2023)10.1080/2162402x.2023.2258011

N/A

0DataRank · unranked

5 citations

Silvia C. Formenti, Sandra Demaria, Maud Charpentier